ResearchIn-Press PreviewPulmonology Open Access | 10.1172/jci.insight.172977
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Rodriguez, L. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Tang, S. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Roque Barboza, W. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Murthy, A. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Tomer, Y. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Cai, T. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Iyer, S. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Chavez, K. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Das, U. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Ghosh, S. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Cooper, C. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Dimopoulos, T. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Babu, A. in: JCI | PubMed | Google Scholar |
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Connelly, C. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by FitzGerald, G. in: JCI | PubMed | Google Scholar
1Pulmonary, Allergy, and Critical Care Division Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
2Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
3Calico Life Sciences, Philadelphia, United States of America
4PENN-CHOP Lung Biology Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Calico Life Sciences, South San Francisco, United States of America
Find articles by Beers, M. in: JCI | PubMed | Google Scholar |
Published November 7, 2023 - More info
Idiopathic Pulmonary Fibrosis (IPF) is a chronic parenchymal lung disease characterized by repetitive alveolar cell injury, myofibroblast proliferation, and excessive extracellular matrix deposition for which unmet need persists for effective therapeutics. The bioactive eicosanoid, prostaglandin F2a, and its cognate receptor FPr (Ptfgr) are implicated as a TGFβ1 independent signaling hub for IPF. To assess this, we leveraged our published murine PF model (IER-SftpcI73T) expressing a disease-associated missense mutation in the surfactant protein C (Sftpc) gene. Tamoxifen treated IER-SftpcI73T mice develop an early multiphasic alveolitis and transition to spontaneous fibrotic remodeling by 28 days. IER-SftpcI73T mice crossed to a Ptgfr null (FPr-/-) line showed attenuated weight loss and gene dosage dependent rescue of mortality compared to FPr+/+ cohorts. IER-SftpcI73T/FPr-/- mice also showed reductions in multiple fibrotic endpoints for which administration of nintedanib was not additive. Single cell RNA sequencing, pseudotime analysis, and in vitro assays demonstrated Ptgfr expression predominantly within adventitial fibroblasts which were reprogrammed to an “inflammatory/transitional” cell state in a PGF2a/ FPr dependent manner. Collectively, the findings provide evidence for a role for PGF2a signaling in IPF, mechanistically identify a susceptible fibroblast subpopulation, and establish a benchmark effect size for disruption of this pathway in mitigating fibrotic lung remodeling.